Gentamicin Delivery to Burkholderia cepacia Group IIIa Strains via Membrane Vesicles from Pseudomonas aeruginosa PAO1

AUTOR(ES)

Allan, Nick D.

FONTE

American Society for Microbiology

RESUMO

When Pseudomonas aeruginosa PAO1 is treated with gentamicin, it releases membrane vesicles containing gentamicin (g-MVs) and peptidoglycan hydrolase, which makes the MVs bactericidal. We evaluate the ability of g-MVs to deliver gentamicin past the intrinsic permeability barrier of group IIIa Burkholderia cepacia and show that strain CEP0248 with low resistance to gentamicin is killed but the highly resistant strain C5424 is not. Immunoelectron microscopy revealed that gentamicin was delivered into both strains, suggesting that there might be another mechanism of resistance in C5424.

Documentos Relacionados

• Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
• Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia
• Pseudomonas aeruginosa PAO1 Kills Caenorhabditis elegans by Cyanide Poisoning
• Catabolism of aromatic biogenic amines by Pseudomonas aeruginosa PAO1 via meta cleavage of homoprotocatechuic acid.
• Characterization of Nutrient-Induced Dispersion in Pseudomonas aeruginosa PAO1 Biofilm